Bayer AG is working on a deal to distribute insulin products produced by Bioton S.A. in China, according to China Knowledge. Bioton is a Polish biotechnology company. Janusz Guy, CEO of Bioton, would say only that the company is choosing a candidate for business cooperation from a number of different companies, a list that includes Bayer. More details..

Stock Symbols: (Frankfurt: BAY) (ASX: SIE)